Seaward Management Limited Partnership lowered its position in Becton, Dickinson and Company (NYSE:BDX) by 1.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,473 shares of the medical instruments supplier’s stock after selling 775 shares during the period. Seaward Management Limited Partnership’s holdings in Becton, Dickinson and were worth $10,909,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Franklin Parlapiano Turner & Welch LLC purchased a new position in shares of Becton, Dickinson and during the first quarter worth $4,920,000. Piedmont Investment Advisors LLC boosted its position in Becton, Dickinson and by 0.9% in the first quarter. Piedmont Investment Advisors LLC now owns 44,389 shares of the medical instruments supplier’s stock worth $8,143,000 after buying an additional 384 shares during the period. Skandinaviska Enskilda Banken AB publ bought a new position in Becton, Dickinson and during the first quarter worth approximately $6,603,000. Ballentine Partners LLC bought a new position in Becton, Dickinson and during the first quarter worth approximately $300,000. Finally, Hendley & Co. Inc. boosted its position in Becton, Dickinson and by 10.7% in the first quarter. Hendley & Co. Inc. now owns 7,766 shares of the medical instruments supplier’s stock worth $1,425,000 after buying an additional 750 shares during the period. Institutional investors and hedge funds own 75.57% of the company’s stock.

Shares of Becton, Dickinson and Company (BDX) traded up 0.04% during midday trading on Wednesday, hitting $201.57. 276,026 shares of the stock were exchanged. Becton, Dickinson and Company has a 1-year low of $161.29 and a 1-year high of $206.63. The stock’s 50-day moving average price is $199.29 and its 200-day moving average price is $188.36. The firm has a market capitalization of $45.87 billion, a price-to-earnings ratio of 58.38 and a beta of 1.05.

Becton, Dickinson and (NYSE:BDX) last announced its quarterly earnings data on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The company had revenue of $3.04 billion during the quarter, compared to analyst estimates of $3.06 billion. During the same quarter last year, the firm posted $2.35 EPS. The firm’s revenue for the quarter was down 5.1% on a year-over-year basis. On average, analysts forecast that Becton, Dickinson and Company will post $9.46 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 8th will be issued a $0.73 dividend. This represents a $2.92 annualized dividend and a yield of 1.45%. The ex-dividend date is Thursday, September 7th. Becton, Dickinson and’s dividend payout ratio (DPR) is currently 83.43%.

TRADEMARK VIOLATION NOTICE: “Becton, Dickinson and Company (BDX) Stake Reduced by Seaward Management Limited Partnership” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/08/16/becton-dickinson-and-company-bdx-stake-reduced-by-seaward-management-limited-partnership-2.html.

A number of research firms have commented on BDX. BidaskClub cut shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Sunday, August 6th. Stifel Nicolaus reaffirmed a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday, August 9th. Cowen and Company reaffirmed a “buy” rating and set a $230.00 price objective on shares of Becton, Dickinson and in a research report on Monday. Barclays PLC reaffirmed an “equal weight” rating and set a $210.00 price objective (up from $205.00) on shares of Becton, Dickinson and in a research report on Thursday, August 10th. Finally, Zacks Investment Research cut shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Monday, August 7th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $195.79.

In related news, insider Thomas E. Polen, Jr. sold 5,971 shares of Becton, Dickinson and stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $197.41, for a total value of $1,178,735.11. Following the completion of the sale, the insider now owns 12,861 shares of the company’s stock, valued at approximately $2,538,890.01. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Ribo Alberto Mas sold 7,463 shares of Becton, Dickinson and stock in a transaction dated Monday, August 14th. The stock was sold at an average price of $201.41, for a total value of $1,503,122.83. Following the completion of the sale, the executive vice president now directly owns 29,323 shares of the company’s stock, valued at approximately $5,905,945.43. The disclosure for this sale can be found here. In the last three months, insiders sold 51,482 shares of company stock valued at $9,871,556. 1.40% of the stock is currently owned by insiders.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.